Harris Associates’s Thermo Fisher Scientific TMO Stock Holding History

Harris Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-541	Closed	-$313K	–	183
2025 Q4	$313K	Hold	541	–	–	﹤0.01%	143
2025 Q3	$262K	Buy	+541	New	+$252K	﹤0.01%	150
2015 Q1	–	Sell	-11,698	Closed	-$1.47M	–	183
2014 Q4	$1.47M	Hold	11,698	–	–	﹤0.01%	143
2014 Q3	$1.42M	Hold	11,698	–	–	﹤0.01%	141
2014 Q2	$1.38M	Hold	11,698	–	–	﹤0.01%	142
2014 Q1	$1.41M	Hold	11,698	–	–	﹤0.01%	141
2013 Q4	$1.3M	Hold	11,698	–	–	﹤0.01%	148
2013 Q3	$1.08M	Hold	11,698	–	–	﹤0.01%	148
2013 Q2	$990K	Buy	+11,698	New	+$974K	﹤0.01%	156

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harris Associates's TMO Position: Q1 2026 in Review

Harris Associates sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 541 shares — an estimated $313K sold.

Harris Associates first reported a position in TMO in Q2 2013 and held it in 9 quarters. The position peaked at $1.47M in Q4 2014. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Harris Associates reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Harris Associates sold 541 Thermo Fisher Scientific shares in Q1 2026, an estimated $313K.
Harris Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 9 quarters.
Harris Associates's Thermo Fisher Scientific position peaked at $1.47M in Q4 2014.
2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Harris Associates's 13F filing for Q1 2026, filed 15 May 2026.